Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

AKTX

AKTX News

Newswire

10:50

Akari Therapeutics shares surge 41.36% intraday after acquiring Peak Bio's ADC platform and focusing on Trop2-targeting AKTX-101 for multiple cancers.

10:45

Akari Therapeutics shares rise 20.62% intraday after acquiring Peak Bio's ADC platform and shifting focus to Trop2-targeted AKTX-101 development for multiple cancers.

19:10

Akari Therapeutics Reports Q4 Earnings, CEO Discusses Oncology Pipeline and Future Plans

16:15

Akari Therapeutics shares surge 13.34% after-hours after appointing Kameel Farag as interim CFO, citing his biotech finance expertise and capital-raising track record.

14:13

Akari Therapeutics shares surge 10.77% intraday after appointing Kameel Farag as interim CFO with $170M+ capital-raising experience.

View More

About AKTX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More